Why the study?
Left atrial enlargement predicts AF recurrence after cryoballoon ablation, and increased left ventricular wall thickness is pathophysiologically linked to LAE and atrial arrhythmias, but the effect of increased LVWT depending on LAE coexistence was unknown.
Does the joint occurrence of left atrial enlargement and increased left ventricular wall thickness increase the risk of arrhythmia recurrence after cryoballoon ablation in patients with atrial fibrillation?
Does the joint occurrence of left atrial enlargement and increased left ventricular wall thickness increase the risk of arrhythmia recurrence after cryoballoon ablation in patients with atrial fibrillation?
The joint presence of left atrial enlargement and increased left ventricular wall thickness identifies a subgroup of atrial fibrillation patients at the highest risk for arrhythmia recurrence following cryoballoon ablation.
May aid post-ablation risk stratification in AF; leaves open whether modifying LAE or LVWT improves outcomes.
BACKGROUND: Left atrial enlargement (LAE) predicts atrial fibrillation (AF) recurrence after cryoballoon-based pulmonary vein isolation (CB). Increased left ventricular wall thickness (LVWT) is pathophysiologically associated with LAE and atrial arrhythmias. AIMS: To assess effect of increased LVWT on long-term outcomes of CB depending on coexistence of LAE. METHODS: LAE was defined using either echocardiography ( > 48 cm³/m²) or multislice computer tomography (MSCT, ≥63 cm³/m²). Increased LVWT was echocardiographic septal/posterior wall thickness > 10 mm in males and > 9 mm in females. All patients achieved 2-year follow-up. RESULTS: Of 250 patients (median [interquartile range, IQR] age of 61 [49.0-67.3] years; 30% female) with AF (40% non-paroxysmal), 66.5% had hypertension, and 27.2% underwent redo procedure. MSCT was done in 76%. During follow-up of 24.5 (IQR, 6.0-31.00) months the clinical success rate was 72%, despite 46% of patients having arrhythmia recurrence. Arrhythmia recurrence risk was increased by LAE and increased LVWT (hazard ratio [HR], 1.801; P = 0.002 and HR, 1.495; P = 0.036; respectively). The highest arrhythmia recurrence (61.9% at 2 years) was among patients with LAE and increased LVWT (33.6% of patients); intermediate (41.8%) among patients with isolated LAE; and lowest among patients with isolated increased LVWT or patients without LAE or increased LVWT (36.8% and 35.2% respectively, P = 0.004). After adjustment for body mass index (BMI), paroxysmal AF, CHA₂DS₂-VASc score, clinically-significant valvular heart disease, and cardiomyopathy, patients with LAE and concomitant increased LVWT diagnosis had a 1.8-times increased risk of arrhythmia recurrence (HR, 1.784; 95% confidence interval [CI], 1.017-3.130; P = 0.043). CONCLUSION: Joint occurrence of LAE and increased LVWT is associated with the highest rate of arrhythmia recurrence after CB for AF.
No takes yet. Share an insight, caveat, or question.
Warmiński et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: